20 articles
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
French study reveals how aging influences metabolic responses to cancer, potentially explaining malnutrition patterns in elderly patients.
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.
Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.
Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.
Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.
A completed Danish trial investigates how blocking IL-6 signaling with tocilizumab alters fat, glucose, and protein metabolism in humans.
VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.
Faith-based weight loss trial compares intermittent fasting to continuous calorie reduction for cancer risk reduction in Black adults.
Czech study reveals how strategic fasting and ketogenic diets can reprogram harmful fat production in obesity.
176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.
Swiss researchers studied how mTOR protein in fat tissue affects metabolism and insulin function throughout the body.
84-person study reveals how targeted nutrition counseling impacts blood sugar, weight, and heart health in diabetic patients.
Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.
169-person study tests whether intermittent fasting and low-carb approaches can reverse insulin resistance and metabolic dysfunction.
Cross-sectional study of 93 healthy adults compared cardiovascular risk factors between vegetarian and non-vegetarian dietary patterns.
12-week controlled feeding study tests whether eating more whole fruit can improve blood sugar control and potentially reverse diabetes.
